Literature DB >> 12085478

The economic burden of lost productivity due to migraine headache: a specific worksite analysis.

Wayne N Burton1, Daniel J Conti, Chin-Yu Chen, Alyssa B Schultz, Dee W Edington.   

Abstract

Large, epidemiologic survey studies have established that migraine headaches affect approximately 6% of men and 18% of women in the United States and that the condition peaks during the prime working years (25 to 55 years of age). The consequent economic burden experienced by employers is substantial. The majority of this economic burden is realized by employers in terms of lost productivity, a combination of costs attributable to absenteeism and to lost productivity while on the job ("presenteeism"). Although large survey studies have produced estimates of national prevalence and have suggested substantial national costs, specific employers are rarely able to apply these projections to their specific workforce. Using demographic and payroll data available from a large financial services corporation with over 80,000 employees, this study used established prevalence data to estimate corporate costs stemming from migraine-related absenteeism and reduced on-the-job productivity to total at least $21.5 M and $24.4 M. In addition, a comparison of predicted prevalence and cost impact was conducted using a simpler and less costly health risk appraisal. This assessment proved to be a reliable tool in assessing prevalence of migraineurs in this corporation's workforce. Its use with a sample of 19,853 employees at this corporation produced prevalence rates of 7.7% of men and 23.4% of women, estimates closely comparable to those of national surveys. Suggestions are made regarding a corporate response to the substantial costs of lost productivity associated with migraine headache.

Entities:  

Mesh:

Year:  2002        PMID: 12085478     DOI: 10.1097/00043764-200206000-00013

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  21 in total

Review 1.  The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research.

Authors:  Wayne N Burton; Stephen H Landy; Kristen E Downs; M Chris Runken
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

2.  Relative magnitude of presenteeism and absenteeism and work-related factors affecting them among health care professionals.

Authors:  Iina Rantanen; Risto Tuominen
Journal:  Int Arch Occup Environ Health       Date:  2010-12-08       Impact factor: 3.015

3.  The Impact of Migraine Disease on Work Productivity and Quality of Life Among the Adults in Riyadh, Saudi Arabia.

Authors:  Rahaf F Alkahtani; Shawg S Alrumaih; Sarah S Algezlan; Rahaf R Almutairi; Basma A Alturki; Raghad M Alanazi; Fahad A Alateeq
Journal:  Cureus       Date:  2022-08-06

4.  Migraine and psychiatric comorbidities among sub-saharan african adults.

Authors:  Bizu Gelaye; B Lee Peterlin; Seblewengel Lemma; Markos Tesfaye; Yemane Berhane; Michelle A Williams
Journal:  Headache       Date:  2012-10-23       Impact factor: 5.887

5.  Investigating the genetic role of aquaporin4 gene in migraine.

Authors:  Elisa Rubino; I Rainero; G Vaula; F Crasto; E Gravante; E Negro; F Brega; S Gallone; L Pinessi
Journal:  J Headache Pain       Date:  2009-02-10       Impact factor: 7.277

6.  Cost-utility analysis of a one-time supervisor telephone contact at 6-weeks post-partum to prevent extended sick leave following maternity leave in The Netherlands: results of an economic evaluation alongside a randomized controlled trial.

Authors:  Kimi Uegaki; Suzanne G M Stomp-van den Berg; Martine C de Bruijne; Mireille N M van Poppel; Martijn W Heymans; Willem van Mechelen; Maurits W van Tulder
Journal:  BMC Public Health       Date:  2011-01-27       Impact factor: 3.295

7.  The development of a new corporate specific health risk measurement instrument, and its use in investigating the relationship between health and well-being and employee productivity.

Authors:  Peter R Mills
Journal:  Environ Health       Date:  2005-01-28       Impact factor: 5.984

8.  Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact.

Authors:  Emina Sokolovic; Franz Riederer; Thomas Szucs; Reto Agosti; Peter Stefan Sándor
Journal:  J Headache Pain       Date:  2013-03-26       Impact factor: 7.277

Review 9.  Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache.

Authors:  Michael H Bennett; Christopher French; Alexander Schnabel; Jason Wasiak; Peter Kranke; Stephanie Weibel
Journal:  Cochrane Database Syst Rev       Date:  2015-12-28

10.  The prevalence of musculoskeletal disorder and association with productivity loss: a preliminary study among labour intensive manual harvesting activities in oil palm plantation.

Authors:  Yee Guan Ng; Shamsul Bahri Mohd Tamrin; Wai Mun Yik; Irwan Syah Mohd Yusoff; Ippei Mori
Journal:  Ind Health       Date:  2013-11-29       Impact factor: 2.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.